about
Images in cardiology: A coronary organic stenosis distal to severe, ergonovine induced spasm: decision makingAcute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and managementCoronary functional tests in the catheterization laboratory - pathophysiological and clinical relevanceA case of fatal stent thrombosis after Carbostent implantation: is clopidogrel alone antiplatelet therapy a safe alternative to aspirin alone antiplatelet therapy?Data on the lipoprotein (a), coronary atherosclerotic burden and vulnerable plaque phenotype in angiographic obstructive coronary artery disease.Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease.Thrombus vaporization by excimer laser angioplasty.Excimer laser coronary angioplasty with manual thrombus aspiration for a case of very late stent thrombosis of sirolimus-eluting stent.Excimer Laser LEsion modification to expand non-dilatable stents: the ELLEMENT registry.INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trialThe combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study.The Same Angiographic Factors Predict Venous and Arterial Graft Patency: A Retrospective Study.Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients.Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion.Nonconventional use of coronary guidewires for ECG recording and emergency pacing.Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty (FORZA) trial: study protocol for a randomized controlled trial.Prevention and treatment of no-reflow.No-reflow: again prevention is better than treatment.New strategies for the management of no-reflow after primary percutaneous coronary intervention.Methods to investigate coronary microvascular function in clinical practice.The central role of conventional 12-lead ECG for the assessment of microvascular obstruction after percutaneous myocardial revascularization.Advances in mechanisms, imaging and management of the unstable plaque.Evolving management of patients treated by drug-eluting stent: prevention of late events.Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial.Stent-related defects in patients presenting with stent thrombosis: differences at optical coherence tomography between subacute and late/very late thrombosis in the Mechanism Of Stent Thrombosis (MOST) study.Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering.A focus on the prognosis and management of ischemic heart disease in patients without evidence of obstructive coronary artery disease.Evaluation of intermediate coronary stenoses in acute coronary syndromes using pressure guidewire.Granulocyte colony-stimulating factor for the treatment of cardiovascular diseases: An update with a critical appraisal.Frequency-domain optical coherence tomography plaque morphology in stable coronary artery disease: sex differences.Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: A Meta-Analysis of Randomized Controlled Trials.Clinical outcome and correlates of coronary microvascular obstruction in latecomers after acute myocardial infarction.Relationship between Serum Inflammatory Biomarkers and Thrombus Characteristics in Patients with ST Segment Elevation Myocardial Infarction.Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.A current approach to heart failure in Duchenne muscular dystrophy.Impact of Culprit Plaque and Atherothrombotic Components on Incomplete Stent Apposition in Patients With ST-Elevation Myocardial Infarction Treated With Everolimus-Eluting Stents - An OCTAVIA Substudy.Comparison of Right and Left Upper Limb Arterial Variants in Patients Undergoing Bilateral Transradial Procedures.Clinical and procedural impact of aortic arch anatomic variants in carotid stenting procedures.Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI.Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis.
P50
Q24673470-13CE7C76-F357-466F-861E-BAFD0EBF47ADQ26830836-00B07C85-ABAB-498B-9AAF-B1C5E215BEA7Q28082101-C7A5A3E1-2D3F-4B7F-9E0A-1459A70AAD56Q28218892-748981EC-5112-4D8C-97AC-F7E0B8DCFD90Q31093954-CA44B04B-ABFB-42D9-80CE-61572331E74AQ31134772-157C7557-EF87-406F-BAB7-28F5B9C09D10Q33529328-C10F1C3A-18A0-47C4-B782-2A1634CA32C8Q33954252-FBC0C26E-E3FF-4787-A4D8-55E982AB4D64Q35056840-B3F23679-255F-43EF-8E92-89D249CD42CAQ36116395-E9F95318-DFC1-4986-B53F-7F330D3E497EQ36248117-4F11AF17-9FC6-4E1E-8883-D28ACC63F7EDQ36444981-799396AC-8F76-40AF-8EAF-8CFA100090EEQ37209164-ABE2931B-B765-4254-B1B1-1FEA7B17F3EFQ37291936-BF6B8B38-445A-44E3-ADD5-591EDFDC1C3FQ37323249-FE07DA67-3C09-478D-AE47-EDD71C7D1808Q37726275-3CE4E347-B28A-4AFB-88B6-377CEDEE0CA4Q37779094-42831B6F-73F8-470B-B994-1DDB67D26B15Q37788437-D59F3912-D21B-4DEC-9C98-29E72AEBC7EDQ37880139-B5C5855D-EB52-4FD8-93A5-569827A1AF18Q38065851-E51CBE75-6BDD-4F2D-8321-B2F529AD92B1Q38167447-92B952D0-8296-4C28-8CF0-579F4672E56CQ38188339-133DC986-ADED-4116-82A7-7AE37E6D5FC7Q38193989-95ED7C40-9F72-47D7-83B9-ADFD8AA518CBQ38413509-3C7C1DBD-3C14-49A3-8F99-F98D7270BBE5Q38438283-888A6A0E-4959-4ABA-B1D0-C6DD629C86DCQ38546135-B4528B54-CA4B-4E5A-AFF2-73A436A0395DQ38574181-C51E6183-6973-4D9C-A376-52BAE1AF044CQ38650389-9E881CA7-FBEC-4B6B-A59F-F9BD2BE602EEQ38672280-DF40A0BA-0DDD-4E46-B0C3-B733DDF162BFQ38712256-D48523D6-DDF9-4877-9276-F5AB09510492Q38755508-F5653282-2B29-44A1-A8B9-071D457D4CDEQ38954236-31227FA9-FD01-4CB5-BC4D-605E43C2D238Q39092117-8B1A188B-36D4-4E25-B09F-4F8ADFB9F8F6Q39192213-24424CDC-4AF2-457D-95D8-093B6A317CC1Q39409211-00E0061B-EDA9-49C6-B88F-90A47E483EE4Q40016322-916E9913-8E0B-4459-B54F-DC7C4F05608AQ40236070-F3724F01-E1A7-49CE-9146-C7DAC340BA78Q40269996-120D032F-956C-405D-8CA1-405EDE621E1CQ40285858-1C94F615-D322-49C7-ACE2-C317D259ABB8Q40385274-DB8A5784-CCF4-42B3-92EF-F7D461810476
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giampaolo Niccoli
@ast
Giampaolo Niccoli
@en
Giampaolo Niccoli
@es
Giampaolo Niccoli
@nl
type
label
Giampaolo Niccoli
@ast
Giampaolo Niccoli
@en
Giampaolo Niccoli
@es
Giampaolo Niccoli
@nl
prefLabel
Giampaolo Niccoli
@ast
Giampaolo Niccoli
@en
Giampaolo Niccoli
@es
Giampaolo Niccoli
@nl
P106
P31
P496
0000-0002-3187-6262